Abiopharma

🔍 Oliver Lawrence T. (Executive)

Company: RGC RESOURCES INC (RGCO)

Report Date: 2026-09-01

Detailed Transactions and Holdings:

• Acquired 9 shares of Common Stock at $21.57 per share (Direct)
  Date: 2026-09-01 | Code: P | equity_swap_involved: 0 | shares_owned_after: 30,156.19 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Employee Stock Options at $27.87 per share (Derivative)
  Date: 2026-09-01 | Code: H | Expires: 2030-04-01 | Exercise: 2020-10-01 | shares_owned_after: 5,000.00
• Holds 0 shares of Employee Stock Options at $22.93 per share (Derivative)
  Date: 2026-09-01 | Code: H | Expires: 2031-05-26 | Exercise: 2021-11-26 | shares_owned_after: 3,000.00
• Holds 0 shares of Employee Stock Options at $19.9 per share (Derivative)
  Date: 2026-09-01 | Code: H | Expires: 2032-07-25 | Exercise: 2023-01-25 | shares_owned_after: 1,000.00
• Holds 0 shares of Employee Stock Options at $16.62 per share (Derivative)
  Date: 2026-09-01 | Code: H | Expires: 2033-10-18 | Exercise: 2024-04-18 | shares_owned_after: 5,000.00

Footnotes:

• F1: Purchases made with optional cash contribution pursuant to the RGC Resources, Inc. Dividend Reinvestment and Stock Purchase Plan.